24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
ANALIEVA 1MG is an Tablet medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ANALIEVA 1MG |
|---|---|
| Composition | Anastrozole Tablets 1 mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablet |
| Packaging | Strip (10x 10) |
| Country of Origin | India |
Anastrozole Tablets 1 mg (Anastrozole Tablets 1 mg) is a widely used Tablet medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ANALIEVA 1 MG (Anastrozole Tablets 1 mg) is a prescription hormone therapy medicine used for the treatment and management of hormone receptor-positive breast cancer in postmenopausal women. It contains Anastrozole 1 mg, a highly effective aromatase inhibitor that helps reduce estrogen production in the body. Since many breast cancers depend on estrogen to grow and spread, lowering estrogen levels can help slow cancer progression and reduce the risk of recurrence.
Breast cancer is one of the most common cancers affecting women globally. In hormone receptor-positive breast cancer, cancer cells use estrogen as a growth signal. ANALIEVA 1 MG works by blocking the aromatase enzyme, which is responsible for converting androgens into estrogen in postmenopausal women. By significantly reducing estrogen levels, the medicine helps prevent cancer cells from receiving the hormonal stimulation they need to survive and multiply.
Anastrozole has become an important part of modern breast cancer treatment protocols and is widely recommended by oncologists for both early-stage and advanced hormone-sensitive breast cancer. It is often prescribed after surgery, radiation therapy, or chemotherapy to support long-term disease control and improve treatment outcomes.
ANALIEVA 1 MG is commonly prescribed for:
• Hormone Receptor-Positive Breast Cancer
• Early-Stage Breast Cancer
• Advanced Breast Cancer
• Metastatic Breast Cancer
• Adjuvant Hormonal Therapy
• Long-Term Breast Cancer Management
• Postmenopausal Breast Cancer Treatment
The medicine is manufactured under strict pharmaceutical quality standards to ensure safety, efficacy, and consistent therapeutic performance. It should only be used under the supervision of qualified healthcare professionals experienced in oncology and hormonal cancer therapy.
Patients receiving ANALIEVA 1 MG may require regular medical monitoring, bone density assessments, cholesterol evaluations, and routine follow-up visits to ensure treatment effectiveness and manage potential side effects.
Due to its proven effectiveness in reducing breast cancer recurrence and supporting long-term disease management, ANALIEVA 1 MG remains an essential medicine in modern breast cancer care.
ANALIEVA 1 MG (Anastrozole Tablets 1 mg) is primarily used for the treatment and management of hormone-sensitive breast cancer.
The medicine is commonly used after primary cancer treatment to reduce the risk of recurrence.
ANALIEVA is specifically designed for breast cancers that depend on estrogen for growth.
Doctors may prescribe Anastrozole to help slow disease progression in advanced-stage breast cancer.
The medicine may be used when breast cancer has spread to other parts of the body.
Anastrozole is frequently included in long-term treatment plans to maintain disease control.
The medicine is widely used in postmenopausal women requiring hormone-based cancer treatment.
Anastrozole belongs to a class of medicines known as aromatase inhibitors.
ANALIEVA works by:
• Blocking the aromatase enzyme
• Reducing estrogen production
• Limiting hormonal stimulation of cancer cells
• Slowing tumor growth
• Helping prevent cancer recurrence
• Supporting long-term breast cancer management
This targeted hormonal approach helps improve treatment outcomes in hormone-sensitive breast cancer patients.
Like all prescription medicines, ANALIEVA 1 MG may cause side effects in some patients. The occurrence and severity of side effects vary from person to person.
Many patients experience episodes of warmth, flushing, or sweating.
Joint stiffness, pain, or discomfort is one of the most commonly reported side effects.
Weakness, tiredness, or reduced energy levels may occur during treatment.
Mild to moderate headaches may develop in some patients.
Bone discomfort or musculoskeletal pain may occur during therapy.
Some patients may experience mild nausea or digestive discomfort.
Changes in mood, irritability, or emotional fluctuations may occur.
Excessive sweating may be experienced by certain individuals.
Difficulty sleeping or changes in sleep patterns may develop during treatment.
Seek immediate medical attention if you experience:
• Severe chest pain
• Symptoms of a stroke
• Severe allergic reactions
• Significant bone fractures
• Vision changes
• Severe breathing difficulty
• Persistent swelling
• Severe weakness or dizziness
Patients should contact their healthcare provider immediately if serious symptoms occur.
The dosage of ANALIEVA 1 MG (Anastrozole Tablets 1 mg) should always be determined by a qualified healthcare professional.
Treatment plans depend on the severity and characteristics of the disease.
Previous cancer treatments and overall health influence treatment decisions.
Doctors may monitor treatment effectiveness and adjust management plans if necessary.
Bone density assessments may be important during long-term treatment.
Age, medical conditions, and concurrent medications may affect treatment planning.
• Take the tablet exactly as prescribed.
• Swallow the tablet whole with water.
• Take the medicine at the same time every day.
• Continue treatment as directed by your healthcare provider.
• Do not skip doses.
• Do not stop treatment without medical advice.
Regular follow-up appointments are essential for effective disease management.
Before starting treatment, patients should inform their doctor if they have:
• Osteoporosis
• Low bone density
• Liver disease
• Heart disease
• High cholesterol
• Previous hormonal treatment complications
Patients should also disclose all prescription medicines, supplements, and herbal products currently being used to avoid possible drug interactions.
This medicine is generally intended for postmenopausal women and should not be used during pregnancy or breastfeeding unless specifically directed by a healthcare professional.
• Store in a cool and dry place.
• Protect from direct sunlight and moisture.
• Keep out of reach of children.
• Store at recommended room temperature.
• Trusted Anastrozole formulation
• Effective hormone therapy for breast cancer
• Helps reduce estrogen production
• Supports long-term disease management
• Manufactured under strict pharmaceutical quality standards
• Suitable for modern oncology treatment protocols
• Helps lower the risk of breast cancer recurrence
It is primarily used for the treatment and management of hormone receptor-positive breast cancer in postmenopausal women.
Anastrozole is an aromatase inhibitor that reduces estrogen production and helps control hormone-sensitive breast cancer.
No, it is a hormone therapy medicine that works differently from traditional chemotherapy.
Yes, it is commonly prescribed after primary cancer treatment to help reduce the risk of recurrence.
Yes, long-term treatment may reduce bone density, making regular monitoring important.
Yes, doctors often recommend bone density tests, cholesterol monitoring, and routine medical assessments during treatment.
No, treatment should only be modified or discontinued under medical supervision.
Yes, this medicine should always be used under the guidance of qualified healthcare professionals experienced in oncology and hormonal therapy.